Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis
R. Wilson, T. Welte, E. Polverino, A. De Soyza, H. W. Greville, A. E. O‘Donnell, J. Alder, P. Reimnitz, B. Hampel (London, Newcastle upon Tyne, United Kingdom; Hannover, Wuppertal, Berlin, Germany; Barcelona, Spain; Adelaide, Australia; Washington, Montville, United States Of America)
Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Wilson, T. Welte, E. Polverino, A. De Soyza, H. W. Greville, A. E. O‘Donnell, J. Alder, P. Reimnitz, B. Hampel (London, Newcastle upon Tyne, United Kingdom; Hannover, Wuppertal, Berlin, Germany; Barcelona, Spain; Adelaide, Australia; Washington, Montville, United States Of America). Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis. Eur Respir J 2011; 38: Suppl. 55, 1929
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: